Latest period
363.21M
YoY change
+0.1%
5Y CAGR
+0.1%
Peak year (2025)
360.23M
Latest annual
360.23M
Shares Outstanding history chart for CME Group (CME) from 2000 to 2025
Latest: 360.23M
Shares Outstanding growth chart for CME Group (CME) from 2000 to 2025
Latest: +0.1%
Shares Outstanding history table for CME Group (CME) from 2000 to 2025
| 2025 | 360.23M | +0.1% | +289,000 | ||
| 2024 | 359.94M | +0.1% | +444,000 | ||
| 2023 | 359.50M | +0.1% | +319,000 | ||
| 2022 | 359.18M | +0.1% | +252,000 | ||
| 2021 | 358.93M | +0.1% | +405,000 | ||
| 2020 | 358.52M | +0.1% | +285,000 | ||
| 2019 | 358.24M | +4.2% | +14.50M | ||
| 2018 | 343.74M | +1.0% | +3.51M | ||
| 2017 | 340.23M | +0.4% | +1.26M | ||
| 2016 | 338.97M | +0.3% | +1.07M | ||
| 2015 | 337.89M | +0.5% | +1.83M | ||
| 2014 | 336.06M | +0.5% | +1.67M | ||
| 2013 | 334.40M | +0.6% | +2.08M | ||
| 2012 | 332.32M | -0.4% | -1.49M | ||
| 2011 | 333.81M | +0.4% | +1.33M | ||
| 2010 | 332.48M | -0.1% | -265,000 | ||
| 2009 | 332.74M | +12.9% | +37.91M | ||
| 2008 | 294.83M | +33.7% | +74.30M | ||
| 2007 | 220.53M | +25.6% | +44.91M | ||
| 2006 | 175.62M | +0.8% | +1.43M | ||
| 2005 | 174.19M | +1.2% | +2.14M | ||
| 2004 | 172.05M | +1.4% | +2.38M | ||
| 2003 | 169.67M | +12.9% | +19.37M | ||
| 2002 | 150.30M | +2.7% | +3.94M | ||
| 2001 | 146.37M | +1.7% | +2.49M | ||
| 2000 | 143.87M | — | — |
- 2025360.23M+0.1%
- 2024359.94M+0.1%
- 2023359.50M+0.1%
- 2022359.18M+0.1%
- 2021358.93M+0.1%
- 2020358.52M+0.1%
- 2019358.24M+4.2%
- 2018343.74M+1.0%
- 2017340.23M+0.4%
- 2016338.97M+0.3%
- 2015337.89M+0.5%
- 2014336.06M+0.5%
- 2013334.40M+0.6%
- 2012332.32M-0.4%
- 2011333.81M+0.4%
- 2010332.48M-0.1%
- 2009332.74M+12.9%
- 2008294.83M+33.7%
- 2007220.53M+25.6%
- 2006175.62M+0.8%
- 2005174.19M+1.2%
- 2004172.05M+1.4%
- 2003169.67M+12.9%
- 2002150.30M+2.7%
- 2001146.37M+1.7%
- 2000143.87M—
Shares Outstanding values are taken from CME Group's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at CME Group (CME)
According to CME Group's latest reported financial statements, the company's latest reported diluted shares outstanding is 363.21M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, CME Group (CME) diluted shares outstanding totalled 360.23M – edged up 0.1% year-over-year.
Looking at the 2020–2025 (5 years) stretch, CME Group diluted shares outstanding compounded at +0.1% per year, sustaining 13 straight years of year-over-year growth.
The record annual diluted shares outstanding stands at 360.23M, reached in 2025; the historical low of 143.87M was recorded in 2000.
CME Group Shares Outstanding by Year
CME Group Shares Outstanding 2025: 360.23M
CME Group diluted shares outstanding in 2025 was 360.23M, edged up 0.1% from 2024. This figure represents the highest annual value in the available history.
CME Group Shares Outstanding 2024: 359.94M
2024's diluted shares outstanding for CME Group came in at 359.94M, edged up 0.1% from 2023.
CME Group Shares Outstanding 2023: 359.50M
CME Group posted diluted shares outstanding of 359.50M in 2023, edged up 0.1% from 2022.
CME Group Shares Outstanding 2022: 359.18M
In 2022, CME Group reported diluted shares outstanding of 359.18M, edged up 0.1% from 2021.
CME Group Shares Outstanding 2021: 358.93M
CME Group diluted shares outstanding in 2021 was 358.93M.
See more financial history for CME Group (CME).
Sector peers by Shares Outstanding
Financial Services peers of CME Group (CME), ranked by their latest diluted shares outstanding
| 7.55B | |
| 3.22B | |
| 2.79B | |
| 2.16B | |
| 1.97B | |
| 1.59B | |
| 898.00M | |
| 317.60M |
- 3.22B
- 2.79B
- 1.97B
- 1.59B
- 898.00M
- 317.60M
Frequently asked questions
CME Group (CME) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation